Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Zack just upgraded AEZS to #1. Lol.
I have the Zacks app and it upgraded AEZS to a buy. Last week it was at a hold. Don't have a link.
Yup! And trading at $.49 right now!
Thanks @swing for the heads up. In at $1.12
$BLIN
I like that chart nice find!!
Sorry Matt24d thought you were talking to me :)! Sorry!
Is the link posted on my previous post?
HTM
today at 11:50 on Seeking Alpha!
http://seekingalpha.com/article/2112693?source=iphoneportfolioapp_email
Buying in at $.75 now!
Right on the money AF! Soon!
Sorry must have missed it!thanks !
On HTM?
HTM @.90 now. Even before ER?
Earning out..... Kinda disappointed
Already at $1.00 pre market
HTM hits a buck pre market.
"Expected to report better than expected earnings."
Closing Update: Stocks Decline on Below-Consensus Manufacturing Index, Biotech Selling Blitz
04:13 PM EDT, 03/24/2014 (MT Newswires) -- Weighed down by weaker than expected manufacturing data, heavy profit-taking in biotechs and small caps, as well as pressure on global equities, U.S. stocks extended last Friday's losses, with the Nasdaq Composite putting in its worst performance in nearly two months.
After erasing early gains tied to the better-than-expected Chicago Fed index and expectations that the Chinese government will introduce additional stimulus measures, stocks deteriorated throughout the day, with the sell-off triggered by a larger than expected drop in the Markit PMI and brisk selling in the biotech sector. Biotechs came under attack following Congressional criticism against Gilead Sciences (GILD) for its $1,000 Hepatitis C pill, raising overvaluation concerns for the entire sector.
Today's economic data generated mixed reaction from the financial markets starting with the better than expected Chicago Fed National Activity index which jumped to 0.14 from -0.39 in January, and beating expectations of 0.10.
Unfortunately, the case for a rebound in manufacturing was lost on the larger than expected decline in the Markit purchasing managers index, to 55.5 in March from 57.1 in February. Although the index is still above the 50.0 expansionary threshold, it declined below the 56.5 level the street was expecting.
Here's where the markets stand at the close:
US MARKETS
Dow Jones Industrial Index was down 26 points (-0.2%) at 16,276
S&P 500 was down 9 points (-0.5%) at 1,857
Nasdaq Composite Index was down 50 points (-1.2%) at 4,226
GLOBAL SENTIMENT
FTSE 100 was down 0.56%
Nikkei 225 was up 1.77%
Hang Seng Index was up 1.91%
Shanghai China Composite Index was up 0.91%
UPSIDE MOVERS
(+) IDN Expected to report better than expected Q4 earnings before Tuesday's open
(+) CREG Reported that Q4 earnings more than doubled from the same period last year
(+) NUS Received a minimal $540,000 fine from Chinese regulators
DOWNSIDE MOVERS
(-) NFLX Investor Carl Ichan revealed he has sold half his position
(-) TIF Goldman downgraded the stock to Buy from Conviction Buy, lowered PT $1
(-) MNGA Turned negative after company unveiled its mobile liquid biomass solution at the 7th Annual International Biomass Conference & Expo.
(-) GALT Posted a 2013 net loss on Friday that increased year over year.
http://www.mtnewswires.com © 2014 MT Newswires, a Division of MidnightTrader, Inc. All rights reserved.
Sent from my iPad
News on IDN earnings, see bottom of page. "Better than expected results."
Closing Update: Stocks Decline on Below-Consensus Manufacturing Index, Biotech Selling Blitz
04:13 PM EDT, 03/24/2014 (MT Newswires) -- Weighed down by weaker than expected manufacturing data, heavy profit-taking in biotechs and small caps, as well as pressure on global equities, U.S. stocks extended last Friday's losses, with the Nasdaq Composite putting in its worst performance in nearly two months.
After erasing early gains tied to the better-than-expected Chicago Fed index and expectations that the Chinese government will introduce additional stimulus measures, stocks deteriorated throughout the day, with the sell-off triggered by a larger than expected drop in the Markit PMI and brisk selling in the biotech sector. Biotechs came under attack following Congressional criticism against Gilead Sciences (GILD) for its $1,000 Hepatitis C pill, raising overvaluation concerns for the entire sector.
Today's economic data generated mixed reaction from the financial markets starting with the better than expected Chicago Fed National Activity index which jumped to 0.14 from -0.39 in January, and beating expectations of 0.10.
Unfortunately, the case for a rebound in manufacturing was lost on the larger than expected decline in the Markit purchasing managers index, to 55.5 in March from 57.1 in February. Although the index is still above the 50.0 expansionary threshold, it declined below the 56.5 level the street was expecting.
Here's where the markets stand at the close:
US MARKETS
Dow Jones Industrial Index was down 26 points (-0.2%) at 16,276
S&P 500 was down 9 points (-0.5%) at 1,857
Nasdaq Composite Index was down 50 points (-1.2%) at 4,226
GLOBAL SENTIMENT
FTSE 100 was down 0.56%
Nikkei 225 was up 1.77%
Hang Seng Index was up 1.91%
Shanghai China Composite Index was up 0.91%
UPSIDE MOVERS
(+) IDN Expected to report better than expected Q4 earnings before Tuesday's open
(+) CREG Reported that Q4 earnings more than doubled from the same period last year
(+) NUS Received a minimal $540,000 fine from Chinese regulators
DOWNSIDE MOVERS
(-) NFLX Investor Carl Ichan revealed he has sold half his position
(-) TIF Goldman downgraded the stock to Buy from Conviction Buy, lowered PT $1
(-) MNGA Turned negative after company unveiled its mobile liquid biomass solution at the 7th Annual International Biomass Conference & Expo.
(-) GALT Posted a 2013 net loss on Friday that increased year over year.
http://www.mtnewswires.com © 2014 MT Newswires, a Division of MidnightTrader, Inc. All rights reserved.
Sent from my iPad
What a day! Tomorrow will be another fun one!
Nice!
IDN- IMO- peeps will hold on till tomorrow's earnings news,
Nice! You think the price will dive at open on MNGA today?
Sorry (MT news wire)
(My news wire)
MNGA (+30.67%) set to make "major announcement at Bio Mass MARCH 24!
Hope so. This thing is already movin early!
Agreed! Was waiting for the dump Friday just before market closed in MNGA. I figured if people didn't dump there is some value to it. If a sell off happened I was out. That is my logic anyway! But agreed there is a reason why MNGA was up 60% and held.
What a day!! Hope everyone did well!
Broke prior resistance, Iam out! Very disappointed with this stock.
Correction March 17 is earnings report. My appologizes, sorry folks.
Earnings tomorow!
Tanking!
Finally!
Why can't I buy?
OGNG is on the move!
So long guys it's been a fun few months ridin the hrid train, I sold short today can't wait any longer good luck to everyone!
Zzzzz......$HHII
Those LOI don't carry much positive weight with investors huh?